Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies, Nanosys in Quantum Dot Licensing Deal

NEW YORK (GenomeWeb News) – Life Technologies and Nanosys have entered into a cross-licensing deal to share rights to intellectual property covering fluorescent nanocrystals, which are also called quantum dots.

The firms said that the deal is expected to result in the development of new tools to detect counterfeit products worldwide. The firms said that between them they have over 270 patents and applications, including 84 issued US patents, for using fluorescent nanocrystals.

"Life Technologies' quantum dots are currently being used in life science research and pathology, but there are vast opportunities to use them in a wide variety of applications," Paul Grossman, senior VP of corporate development and strategy for Life Technologies, said in a statement today. "Our new partnership with Nanosys will allow both companies to expand the opportunities for our combined technologies, and further the reach of Life Technologies into the applied markets."

The firms estimated that the global counterfeit good trade, excluding counterfeit money, is around $1 trillion annually. They said that the quantum dots technology will enable manufacturers to trace the source of their materials and manage and track product shipments.

Financial and further terms of the licensing agreement were not disclosed.

In 2005, Invitrogen, which is now a division of Life Technologies, purchased Quantum Dot, a firm that makes the QDot semiconductor nanocrystals. Invitrogen said at the time that the particles demonstrate unique optical properties, such as photostability, narrow emission spectra, and brightness, and can be used in a wide range of applications in life-science research including gene expression and proteomics.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.